Quantitative Proteomic Approach to Understand Metabolic Adaptation in Non-Small Cell Lung Cancer-Reference-Cited by-同舟云学术

Quantitative Proteomic Approach to Understand Metabolic Adaptation in Non-Small Cell Lung Cancer

Published:2014-08-25 Issue:11 Volume:13 Page:4695-4704
ISSN:1535-3893
Container-title:Journal of Proteome Research
language:en
Short-container-title:J. Proteome Res.

Author:

Martín-Bernabé Alfonso¹²³⁴,Cortés Roldán¹,Lehmann Sylvia G.²³⁴,Seve Michel²³⁴,Cascante Marta¹,Bourgoin-Voillard Sandrine²³⁴

Affiliation:

1. Department of Biochemistry and Molecular Biology, IBUB, Faculty of Biology, Universitat de Barcelona and Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), 08007 Barcelona, Spain

2. Univ. Grenoble Alpes, IAB, Plateforme de Protéomique PROMETHEE, F-38000 Grenoble, France

3. INSERM, IAB, Plateforme de Protéomique PROMETHEE, F-38000 Grenoble, France

4. CHU de Grenoble, IAB, Institut de Biologie et de Pathologie, Plateforme de Protéomique PROMETHEE, F-38000 Grenoble, France

Funder

European Commission

Generalitat de Catalunya

BioHealth Computing Erasmus Mundus

COSMOS research

Ministerio de Ciencia e Innovación of Spain

Publisher

American Chemical Society (ACS)

Subject

General Chemistry,Biochemistry

Link

https://pubs.acs.org/doi/pdf/10.1021/pr500327v

Reference42 articles.

1. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008

2. Lung Cancer: Are we up to the Challenge?

3. Acquired resistance of lung adenocarcinoma to EGFR-tyrosine kinase inhibitors gefitinib and erlotinib

4. Primary and Acquired Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Non-small Cell Lung Cancer: An Update

5. KRAS Mutation Is an Important Predictor of Resistance to Therapy with Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Non–Small-Cell Lung Cancer

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Energy metabolism as the hub of advanced non-small cell lung cancer management: a comprehensive view in the framework of predictive, preventive, and personalized medicine;EPMA Journal;2024-04-08

2. Metabolic barriers in non-small cell lung cancer with LKB1 and/or KEAP1 mutations for immunotherapeutic strategies;Frontiers in Oncology;2023-08-22

3. The Tumor Suppressor Kinase LKB1: Metabolic Nexus;Frontiers in Cell and Developmental Biology;2022-04-28

4. Hippocalcin-like 1 is a key regulator of LDHA activation that promotes the growth of non-small cell lung carcinoma;Cellular Oncology;2022-01-31

5. Quantitative Proteomic Approach Reveals Altered Metabolic Pathways in Response to the Inhibition of Lysine Deacetylases in A549 Cells under Normoxia and Hypoxia;International Journal of Molecular Sciences;2021-03-25